Neurocrine Biosciences
NBIX
#1268
Rank
โ‚ฌ15.75 B
Marketcap
156,68ย โ‚ฌ
Share price
3.33%
Change (1 day)
38.99%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of March 2026 : โ‚ฌ1.15 Billion

According to Neurocrine Biosciences 's latest financial reports the company has โ‚ฌ1.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚ฌ1.26 B21.86%
2024-12-31โ‚ฌ1.03 B10.81%
2023-12-31โ‚ฌ0.93 B1.18%
2022-12-31โ‚ฌ0.92 B46.84%
2021-12-31โ‚ฌ0.62 B-3.55%
2020-12-31โ‚ฌ0.65 B8.8%
2019-12-31โ‚ฌ0.59 B5.19%
2018-12-31โ‚ฌ0.56 B32.32%
2017-12-31โ‚ฌ0.42 B47.16%
2016-12-31โ‚ฌ0.29 B-15.74%
2015-12-31โ‚ฌ0.34 B117.63%
2014-12-31โ‚ฌ0.15 B51%
2013-12-31โ‚ฌ0.10 B-19.32%
2012-12-31โ‚ฌ0.13 B31.57%
2011-12-31โ‚ฌ99.41 M4.23%
2010-12-31โ‚ฌ95.37 M155.59%
2009-12-31โ‚ฌ37.31 M-35.17%
2008-12-31โ‚ฌ57.56 M-53.15%
2007-12-31โ‚ฌ0.12 B-11.22%
2006-12-31โ‚ฌ0.13 B-39.97%
2005-12-31โ‚ฌ0.23 B3.84%
2004-12-31โ‚ฌ0.22 B-38.33%
2003-12-31โ‚ฌ0.35 B53.76%
2002-12-31โ‚ฌ0.23 B-35.39%
2001-12-31โ‚ฌ0.36 B107.28%
2000-12-31โ‚ฌ0.17 B93.08%
1999-12-31โ‚ฌ90.53 M818.22%
1998-12-31โ‚ฌ9.85 M-25.95%
1997-12-31โ‚ฌ13.31 M39.82%
1996-12-31โ‚ฌ9.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
โ‚ฌ11.46 B 893.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ8.23 B 613.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ4.62 B 301.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ0.68 B-40.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ0.89 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.28 B-75.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ1.11 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚ฌ1.21 B 5.47%๐Ÿ‡ฌ๐Ÿ‡ง UK